Alamar Biosciences, Inc. (ALMR) is in Healthcare, Medical Devices, based in United States, listed on NasdaqGS. Market cap 1.80B USD. 52-week range 18.85 to 39.61 USD. Data as of 2026-10-09.
Alamar Biosciences, Inc., a proteomics company, develops a proteomic liquid biopsy platform and sells instruments, consumables, and services to early detection of diseases. The company develops NULISA technology, a proteomics platform that detects and quantifies protein biomarkers. It offers ARGO high throughput (HT) System, a fully automated precision proteomics platform, performs ultra-high sensitivity and multiplexed analysis to support biomarker analysis across the continuum of discovery, ...